Salkind Gene

Salkind Gene is listed in filings as Director at Coeptis Therapeutics Holdings, Inc.. This profile follows SEC Form 4 activity through Feb 13, 2026, including purchase activity. Recent filings connect the profile to Coeptis Therapeutics Holdings, Inc. (COEPW) and Upexi, Inc. (UPXI). The current snapshot covers public activity from Mar 6, 2025 to Feb 13, 2026. Reported amounts are shown as $60.2K to $281.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.